Kisses from Italy Pivots to Biologics & Longevity via Regen Health Merger, Appoints New CEO for Aggressive 2026 Expansion
KITL has more than doubled off its 52-week low of $0 on light trading volume (0.4× avg).
Summary
Kisses from Italy (KITL) announced a transformative business combination with Regen Health Physicians, signaling a strategic pivot into the high-growth biologics and longevity sector. Dr. MD Ajit Dhaliwal, founder of Regen Health, has been appointed as the new CEO, and the company unveiled an aggressive 2026 expansion strategy, including initial clinics in major metropolitan markets and a broader franchise rollout. This event is highly material for the micro-cap company, fundamentally changing its business model and positioning it to capitalize on the rapidly expanding medical spa and peptide therapeutics markets. Traders will closely monitor the execution of this ambitious expansion plan, the successful integration of Regen Health Physicians, and the financial performance of the new medical platform.
At the time of this announcement, KITL was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.00 to $0.01. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.